The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease

被引：0
|
作者：
Hanson, Angela J. [1 ,2 ]
Craft, Suzanne [3 ]
Banks, William A. [1 ,2 ]
机构：
[1] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA
[2] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[3] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA
来源：
CURRENT PHARMACEUTICAL DESIGN | 2015年 / 21卷 / 01期
关键词：
Alzheimer's disease; treatments; APOE genotype; MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; INTRANASAL INSULIN; LOWERING TREATMENT; AMYLOID-BETA; DOUBLE-BLIND; VITAMIN-E; DEMENTIA; RISK; EPSILON-4;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The translation of promising preclinical treatments into effective drugs for Alzheimer's disease (AD) has been challenging. One of the most potent risk factors for sporadic AD is carrier status of the epsilon 4 allele of the apolipoprotein E gene (E4). E4 carriers show a differential response to several therapies which are being investigated as AD treatments, including acetylcholinesterase inhibitors and therapeutics with vascular and metabolic targets. The differential treatment responses of E4 carriers may partially explain why some treatments show a null effect in clinical trials. Understanding the reasons behind these responses is not only important for clinical practice, but may also help us elucidate mechanisms for this neurodegenerative disease.
引用
收藏
页码：114 / 120
页数：7
相关论文
共 50 条
  • [1] APOE genotype and Alzheimer's disease
    Harrington, CR
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (04) : 238 - 238
  • [2] ApoE genotype in Alzheimer's disease determination
    Ivanusa, P.
    Nadizar, N.
    Fabjan, J.
    Kramberger, M. Gregoric
    Pirtosek, Z.
    Bon, J.
    Rozman, D.
    Paska, A. Videtic
    FEBS OPEN BIO, 2021, 11 : 199 - 200
  • [3] APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease
    Lin, Ai-Ling
    Parikh, Ishita
    Yanckello, Lucille M.
    White, Renee S.
    Hartz, Anika M. S.
    Taylor, Chase E.
    McCulloch, Scott D.
    Thalman, Scott W.
    Xia, Mengfan
    McCarty, Katie
    Ubele, Margo
    Head, Elizabeth
    Hyder, Fahmeed
    Sanganahalli, Basavaraju G.
    NEUROBIOLOGY OF DISEASE, 2020, 139
  • [4] Disclosure of APOE Genotype for Risk of Alzheimer's Disease
    Green, Robert C.
    Roberts, J. Scott
    Cupples, L. Adrienne
    Relkin, Norman R.
    Whitehouse, Peter J.
    Brown, Tamsen
    Eckert, Susan LaRusse
    Butson, Melissa
    Sadovnick, A. Dessa
    Quaid, Kimberly A.
    Chen, Clara
    Cook-Deegan, Robert
    Farrer, Lindsay A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (03): : 245 - 254
  • [5] Neuropsychiatric symptoms and the APOE genotype in Alzheimer’s disease
    Marina Del Prete
    Simona Spaccavento
    Angela Craca
    Pietro Fiore
    Paola Angelelli
    Neurological Sciences, 2009, 30 : 367 - 373
  • [6] Neuropsychiatric symptoms and the APOE genotype in Alzheimer's disease
    Del Prete, Marina
    Spaccavento, Simona
    Craca, Angela
    Fiore, Pietro
    Angelelli, Paola
    NEUROLOGICAL SCIENCES, 2009, 30 (05) : 367 - 373
  • [7] Influence of the ApoE genotype on serum APOE levels in Alzheimer's disease patients
    Corzo, L
    Fernandez-Novoa, L
    Zas, R
    Beyer, K
    Lao, JI
    Alvarez, XA
    Cacabelos, R
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 765 - 771
  • [8] The association between APOE genotype and progression of Alzheimer's disease
    Tsolaki, M.
    Bosiki, M.
    Daniilidou, M.
    Pitsalidis, C. H.
    Molyva, D.
    Kounti, F.
    Papassotiropoulos, A.
    Kazis, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 58 - 58
  • [9] APOE genotype and survival in men and women with Alzheimer's disease
    Dal Forno, G
    Carson, KA
    Brookmeyer, R
    Troncoso, J
    Kawas, CH
    Brandt, J
    NEUROLOGY, 2002, 58 (07) : 1045 - 1050
  • [10] Serum lipoprotein profile and APOE genotype in Alzheimer's disease
    Cagnin, A.
    Zambon, A.
    Zarantonello, G.
    Vianello, D.
    Marchiori, M.
    Mercurio, D.
    Micciche, F.
    Ermani, M.
    Leon, A.
    Battistin, L.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2007, (72): : 175 - 179
12345